Jump to main content.


Pesticide Registration Improvement Renewal Act (PRIA 2)
Fee Determination Decision Tree

Note: EPA no longer updates this information, but it may be useful as a reference or resource.

Decision Tree Resources:
Below is the fee for your selected Fee Category for
Fiscal Year 2011 & 2012

Action Code
Description
FY11/FY12
Fee
FY11/FY12 Decision Time
(months)
B660
New product; identical or substantially similar in composition and use to a registered product; no data review or only product chemistry data; cite-all data citation, or selective data citation where applicant owns all required data, or applicant submits specific authorization letter from data owner.  Category also includes 100% re-package of registered end-use or manufacturing-use product that requires no data submission or data matrix.
$1,159.00
3


Do you plan to request either of the following types of waivers?

50% waiver 50% waiver
75% waiver 75% waiver

To pay the fee shown above, go to http://www.pay.gov and follow the instructions.

How to submit your application directly to EPA.


Action Code Interpretation:

An application for registration of an end-use or a manufacturing use microbial or biochemical pesticide product that is substantially similar, identical in its uses and formulation, or that differs only in ways that would not significantly increase the risk of unreasonable adverse effects on the environment to products that are currently registered. The applicant must identify the similar registered products for all active ingredients in the proposed product. All applications require the following:

  • A data matrix is required with the application if it is not a 100% re-packaged product.
  • Product chemistry data (Group A and B) unless the product is identical (e.g., 100% repackaged product). In some cases, product chemistry data can be satisfied as outlined in Pesticide Registration Notice 98-1.
  • The active ingredient(s) must be currently registered and the CSF must include its EPA Registration Number(s).
  • In all cases, the registrant must identify the registered similar product for this category.
  • Acute toxicity requirements must be addressed by using:
  1. The cite-all method
  2. Selective data citation where the applicant owns all required data, or
  3. Applicant submits specific authorization letter from the data owner

The application is not in this category if efficacy, acute toxicity, companion animal safety, and/or child resistant packaging data are submitted and must be reviewed to support the application.  The application does not fall into this category if it contains a request to waive any of these data.   An application that requires review of cited or submitted data other than product chemistry does not belong in this fee category. If the use pattern on the TGAI differs from the proposed products, then additional data are required and the application does not fall within this category.

Substantially similar:  Product must have the same active ingredient, in substantially the same proportion, same chemical composition (solid, liquid, granular), and substantially similar inert ingredients as the already registered product.  In addition, substantially similar means that the proposed product bears the same use pattern.  Adding to or changing existing use patterns excludes the proposed product from treatment as a substantially similar product.  Deleting use patterns is acceptable.

Identical:  Same composition and use patterns as a currently registered end-use product.

Manufacturing Use Product:  A 100% re-package of a manufacturing use product that requires no data submission or data matrix is covered by this category.

Back      Go to the start of the Decision Tree

Publications | Glossary | A-Z Index | Jobs


Local Navigation


Jump to main content.